Launch of two gene COVID-19 test

Paris, France and Camberley, UK – 4 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has launched a CE-Mark approved polymerase chain reaction (PCR) two gene target test for COVID-19. http://novacyt.com/wp-content/uploads/2020/09/Novacyt-launch-of-2-gene-COVID-19-test-ENG.pdf

Visit Page

Launch of respiratory test panel

New test differentiates COVID-19 from common winter diseases Paris, France and Camberley, UK – 27 August 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of its CE-Mark approved polymerase chain reaction (PCR) respiratory test panel, Winterplex™. http://novacyt.com/wp-content/uploads/2020/08/Novacyt-launch-of-respiratory-test-panel-ENGLISH.pdf

Visit Page

Notice of AGM

Paris, France and Camberley, UK – 19 August 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its Annual General Meeting (AGM) will be held as a closed meeting at 2pm CEST/1pm BST on Tuesday 29 September. The AGM comprises both ordinary and extraordinary general meetings. http://novacyt.com/wp-content/uploads/2020/08/Novacyt_Notice-of-AGM-Aug-2020-ENG.pdf

Visit Page